Syndax Pharmaceuticals Inc (NASDAQ:SNDX) showed up in the 13F filings of 223 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | -386,242 | -4.48% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,091,717 | 21.25% | $0.00 |
| Kynam Capital Management, LP | 31 Dec, 2025 | 0 | -469,041 | -5.51% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -221,018 | -41.26% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 208,941 | 3.81% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 627,006 | 14.74% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | -11,062 | -19.57% | $0.00 |
| Bank Of America Corp /De/ | 31 Dec, 2025 | 0 | -2,684,760 | -36.30% | $0.00 |
| Eversept Partners, LP | 31 Dec, 2025 | 0 | -152,906 | -4.41% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 944 | 0.00% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 743,003 | 19.28% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | 235,000 | 11.68% | $0.00 |
| Franklin Resources Inc | 31 Dec, 2025 | 0 | 31,105 | 1.30% | $0.00 |
| Elmind Capital, LP | 31 Dec, 2025 | 0 | 1,855,000 | 0.00% | $0.00 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 31 Dec, 2025 | 0 | -150,000 | -6.00% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 7,204 | 0.49% | $0.00 |
| Hood River Capital Management LLC | 31 Dec, 2025 | 0 | 2,316,553 | 0.00% | $0.00 |
| STEMPOINT CAPITAL LP | 31 Dec, 2025 | 0 | -26,826 | -1.96% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | -399 | -0.02% | $0.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 0 | -37,972 | -2.76% | $0.00 |